Prev：Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer(A21020-5)
Next：Nanoprodrug targeting tumor-associated intracellular bacteria enhances colorectal cancer immunotherapy(PRP1138-11.5)
